Key Takeaway:
- Serious Statin muscle side effects-related muscle disorders are extremely rare, with the study finding only about 0.04% of patients at high long-term risk.
- Researchers developed a personalized risk prediction tool to help doctors assess an individual’s likelihood of severe muscle side effects.
- Experts say the heart-protective benefits of statins far outweigh the small risk of serious muscle complications and encourage patients to consult doctors before stopping treatment.
Statin muscle side effects linked to statins are exceedingly rare, according to research published Thursday in The Lancet Digital Health, with scientists also introducing a tool that helps doctors predict an individual patient’s risk.
The study analyzed medical records from nearly 6 million adults in the United Kingdom and found that only about 0.04% of people had a 10-year risk greater than 10% of developing severe statin-related muscle disorders. Researchers said the findings reinforce decades of evidence showing statins are generally safe while offering substantial protection against heart attacks and strokes.
Heart disease remains the world’s leading cause of death, and statins can reduce low-density lipoprotein, or LDL, cholesterol by as much as 60%. Despite extensive safety data spanning more than 50 years, many eligible patients either never begin treatment or stop taking the medication because of concerns about side effects.
Less than half of the estimated 50 million Americans who could benefit from statins take them, while as many as one-third never fill their prescriptions. Previous research also shows that about 40% of patients discontinue statins within three months of starting treatment.
“There is a huge worry in the general population about these drugs based on rare side effects,” said Dr. Nishant Shah, a preventive cardiologist at Duke Health who was not involved in the study.
The researchers developed a clinical tool that estimates a patient’s likelihood of developing severe muscle complications, including myopathy and rhabdomyolysis, a rare condition that can become life-threatening when damaged muscle tissue releases toxins into the bloodstream.
Experts Say Benefits Far Outweigh Risks
The study’s findings suggest severe statin muscle side effects occur even less frequently than previous estimates. Earlier guidance from the American Heart Association placed the risk of myopathy at less than 1% and rhabdomyolysis at less than 0.1%.
“Even if you increase that tenfold, that is still a very tiny risk,” said Dr. Bart Duell, a professor of medicine at Oregon Health and Science University who was not involved in the study. He said the little possibility of muscle-related side effects should not discourage appropriate statin use.
Clinical trials have shown that while some patients report mild muscle pain after starting statins, many of those symptoms are unrelated to the medication itself.
Dr. Steve Nissen, chief academic officer of Cleveland Clinic’s Heart, Vascular & Thoracic Institute, said he has never hospitalized a patient for a statin-related muscle disorder during four decades of practice. Nissen consults for several pharmaceutical companies that manufacture statins, but said he receives no financial compensation.
Researchers Target Misinformation With Personalized Care
Study co-author Ting Cai of the University of Oxford said misinformation and anecdotal accounts have contributed to exaggerated fears about statin muscle side effects.
“Often, people read numbers based on a whole population, or an anecdote about someone who had complications, but they don’t know what will happen to them based on their personalized information,” Cai said.
Researchers said the new prediction tool allows clinicians to assess individual risk using factors such as age, lifestyle, and existing medical conditions. The model distinguishes mild muscle symptoms from the much rarer serious disorders that require medical attention.
Experts said patients experiencing muscle discomfort should consult their physicians rather than stop treatment on their own. Doctors can lower the dosage, switch medications, or consider alternative cholesterol-lowering therapies when appropriate if statin muscle side effects are suspected.
Duell said the overall evidence should reassure patients considering statin therapy.
“The horror stories people talk about are very unlikely to occur,” he said.
Visit The Lifesciences Magazine to read more.
